Sarwat Dimitri, MD
Anesthesiology · Framingham, MANPI 1659352979
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 44.3% of the total. Reporting peaked in 2024 at $641 and has fallen 50.1% since, to $320 in 2025. Among anesthesiology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $22.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$868
- Sanofi$338
- Takeda Pharmaceuticals U.S.A., Inc.$273
- Johnson & Johnson$75
- Amgen$67
- Fresenius Kabi USA, LLC$45
- plus $292 from 11 others
What the payments were for
- Food & beverage$1,959100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 45 | $868 |
| Sanofi | 11 | $338 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $273 |
| Johnson & Johnson | 4 | $75 |
| Amgen | 2 | $67 |
| Fresenius Kabi USA, LLC | 2 | $45 |
| QOL Medical, LLC | 2 | $42 |
| Madrigal Pharmaceuticals | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Bristol Myers Squibb | 1 | $31 |
| Pfizer | 1 | $30 |
| Organon | 1 | $27 |
| Ardelyx, Inc. | 1 | $23 |
| AbbVie | 1 | $22 |
| Braintree Laboratories, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Alfasigma USA, Inc. | 1 | $14 |
How this compares
$1,959 in reported general payments places this provider in the 90th percentile of 1,585 anesthesiology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anesthesiology in Framingham
- James StreisandCambridge$380K
- Douglas ShookBoston$267K
- Paula BokeschLexington$244K
- Robert YongBoston$231K
- Michael DambraBoston$194K
- Jasmine PatelWorcester$180K
- Robert TruogBoston$172K
- Mary Ellen McCannBoston$140K
- Stanton ShernanBoston$136K
- Edgar RossBoston$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.